Jabre Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-12,500
| Closed | -$1.55M | – | 176 |
|
|
2018
Q2 | $1.55M | Sell |
12,500
-17,500
| -58% | -$2.17M | 0.1% | 58 |
|
|
2018
Q1 | $3.34M | Sell |
30,000
-5,000
| -14% | -$557K | 0.72% | 41 |
|
|
2017
Q4 | $4.19M | Buy |
+35,000
| New | +$4.19M | 0.87% | 45 |
|
|
2013
Q4 | – | Sell |
-107,422
| Closed | -$12.1M | – | 138 |
|
|
2013
Q3 | $12.1M | Buy |
+107,422
| New | +$12.1M | 1.36% | 14 |
|